相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Interferon-Gamma Release Assay Versus Tuberculin Skin Test for Tuberculosis Screening in Inflammatory Bowel Disease
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay
G. Matulis et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Screening for tuberculosis infection prior to initiation of anti-TNF therapy
Ajit Lalvani et al.
AUTOIMMUNITY REVIEWS (2008)
Reproducibility of QuantiFERON-TB gold in-tube assay
Sharon Perry et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis
Yoshihiro Kobashi et al.
INTERNAL MEDICINE (2008)
Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression
Farba Karam et al.
PLOS ONE (2008)
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Y. Kobashi et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea
Jong Wook Yun et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Interferon γ assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration
Hiroki Takahashi et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-α agents:: the Newcastle (UK) experience
A. Pratt et al.
RHEUMATOLOGY (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis
Yoshihiro Kobashi et al.
CLINICAL INFECTIOUS DISEASES (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment
LP Ormerod et al.
THORAX (2005)
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona et al.
ARTHRITIS AND RHEUMATISM (2005)
High Incidence of Anergy in Inflammatory Bowel Disease Patients Limits the Usefulness of PPD Screening Before Infliximab Therapy
William S. Mow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Recommendations about the prevention and management of tuberculosis in patients taking infliximab
D Salmon
JOINT BONE SPINE (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
